G-protein Pathway Suppressor 2 (GPS2) Interacts with the Regulatory Factor X4 Variant 3 (RFX4_v3) and Functions as a Transcriptional Co-activator*

RFX4_v3 (regulatory factor X4 variant 3) is a brain-specific isoform of the transcription factor RFX4. Insertional mutagenesis in mice demonstrates that Rfx4_v3 is crucial for normal brain development. Many genes involved in critical processes during brain morphogenesis are dysregulated in Rfx4_v3 mutant brains. For example, Cx3cl1 is a CX3C-type chemokine that is abundant in brain and is a direct transcriptional target of RFX4_v3 through a specific promoter X-box (X-box 1), the responsive element for RFX proteins. To identify potential interacting partners for RFX4_v3, we performed yeast two-hybrid analysis. Nine candidate interactors were identified, including GPS2 (G-protein pathway suppressor 2). Indirect immunofluorescence demonstrated that GPS2 and RFX4_v3 co-localized to the nucleus. Both GPS2 and RFX4_v3 mRNAs were also present in most portions of the adult mouse brain as well as in brains at different ages, suggesting that the two proteins could bind to each other. Co-immunoprecipitation assays indicated that physical interactions between GPS2 and RFX4_v3 did indeed occur. Furthermore, GPS2 was recruited to the Cx3cl1 promoter by RFX4_v3 and potentiated RFX4_v3 transactivation on this promoter through X-box 1, suggesting that the protein-protein interaction was functionally relevant. GPS2 bound to both the carboxyl-terminal region (amino acids 575-735) and the middle region (amino acids 250-574) of the RFX4_v3 protein. RFX4_v3 amino acids 1-574 stimulated the Cx3cl1 promoter to a similar extent as the full-length RFX4_v3 protein; however, deletion of the carboxyl-terminal region of RFX4_v3 impaired the co-activating abilities of GPS2. Based on these data, we conclude that GPS2 interacts with RFX4_v3 to modulate transactivation of genes involved in brain morphogenesis, including Cx3Cl1.

[1]  J. Kleinschmidt,et al.  Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm. , 1994, The Journal of biological chemistry.

[2]  E. Androphy,et al.  AMF-1/Gps2 Binds p300 and Enhances Its Interaction with Papillomavirus E2 Proteins , 2000, Journal of Virology.

[3]  J. Foley,et al.  Enhanced Postischemic Functional Recovery in CYP2J2 Transgenic Hearts Involves Mitochondrial ATP-Sensitive K+ Channels and p42/p44 MAPK Pathway , 2004, Circulation research.

[4]  E. Ikonen,et al.  Mobilization of late-endosomal cholesterol is inhibited by Rab guanine nucleotide dissociation inhibitor , 2000, Current Biology.

[5]  J. Licht,et al.  Critical Residues within the BTB Domain of PLZF and Bcl-6 Modulate Interaction with Corepressors , 2002, Molecular and Cellular Biology.

[6]  V. Staiger,et al.  Differentiation of mouse embryonic stem cells into a defined neuronal lineage , 2004, Nature Neuroscience.

[7]  S. Liour,et al.  Differentiation of radial glia‐like cells from embryonic stem cells , 2003, Glia.

[8]  A novel protein (Fbf-1) that binds to CD95/APO-1/FAS and shows sequence similarity to trichohyalin and plectin. , 2000, Biochimica et biophysica acta.

[9]  W. Xie,et al.  Two human cDNAs, including a homolog of Arabidopsis FUS6 (COP11), suppress G-protein- and mitogen-activated protein kinase-mediated signal transduction in yeast and mammalian cells , 1996, Molecular and cellular biology.

[10]  G. Kirov,et al.  Identification of a potential Bipolar risk haplotype in the gene encoding the winged-helix transcription factor RFX4 , 2005, Molecular Psychiatry.

[11]  Sandra A. Kinnear,et al.  Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System1 , 2000, The Journal of Immunology.

[12]  D. Stumpo,et al.  Identification of potential target genes for RFX4_v3, a transcription factor critical for brain development , 2006, Journal of neurochemistry.

[13]  M. Griswold,et al.  Formation of hMSH4-hMSH5 heterocomplex is a prerequisite for subsequent GPS2 recruitment. , 2006, DNA repair.

[14]  Wesley I. Sundquist,et al.  Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 Budding , 2001, Cell.

[15]  E. Androphy,et al.  Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain , 1997, Molecular and cellular biology.

[16]  X. Chen,et al.  Calcium Signals Control Wnt-Dependent Dendrite Growth , 2006, Neuron.

[17]  S. Batalov,et al.  Antisense Transcription in the Mammalian Transcriptome , 2005, Science.

[18]  A. Fukamizu,et al.  Neurochondrin Negatively Regulates CaMKII Phosphorylation, and Nervous System-specific Gene Disruption Results in Epileptic Seizure* , 2005, Journal of Biological Chemistry.

[19]  I. Cobos,et al.  Graded phenotypic response to partial and complete deficiency of a brain-specific transcript variant of the winged helix transcription factor RFX4 , 2003, Development.

[20]  P. Blackshear,et al.  Necrosis Factor Alpha Mrna Deadenylation and Destabilization of Tumor Au-rich Elements and Promotes the Evidence That Tristetraprolin Binds To , 1999 .

[21]  K. Jeang,et al.  A Human Suppressor of c-Jun N-terminal Kinase 1 Activation by Tumor Necrosis Factor α* , 1997, The Journal of Biological Chemistry.

[22]  Yoshio Miki,et al.  Human Regulatory Factor X 4 (RFX4) Is a Testis-specific Dimeric DNA-binding Protein That Cooperates with Other Human RFX Members* , 2002, The Journal of Biological Chemistry.

[23]  Stephen K. Burley,et al.  Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding , 2000, Nature.

[24]  G. Rubin,et al.  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Huszar,et al.  Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury , 2002, Journal of Neuroimmunology.

[26]  Brian T Chait,et al.  The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. , 2002, Molecular cell.

[27]  J. Abrams,et al.  Fractalkine protein localization and gene expression in mouse brain , 2003, Journal of neuroscience research.

[28]  E. Androphy,et al.  AMF1 (GPS2) Modulates p53 Transactivation , 2001, Molecular and Cellular Biology.

[29]  W. Scheper,et al.  Ubiquitin proteasome system as a pharmacological target in neurodegeneration , 2006, Expert review of neurotherapeutics.

[30]  R. Colbran,et al.  Calcium/calmodulin-dependent protein kinase II and synaptic plasticity , 2004, Current Opinion in Neurobiology.

[31]  C. Ucla,et al.  The Transcription Factor RFX3 Directs Nodal Cilium Development and Left-Right Asymmetry Specification , 2004, Molecular and Cellular Biology.

[32]  S. Silverstein,et al.  Gps2, a Protein Partner for Human Papillomavirus E6 Proteins , 2001, Journal of Virology.

[33]  Jun Qin,et al.  Purification and functional characterization of the human N‐CoR complex: the roles of HDAC3, TBL1 and TBLR1 , 2003, The EMBO journal.

[34]  R. Fukumura,et al.  Restricted Expression and Photic Induction of a Novel Mouse Regulatory Factor X4 Transcript in the Suprachiasmatic Nucleus* , 2004, Journal of Biological Chemistry.

[35]  T. Tamiya,et al.  Identification of glioma‐specific RFX4‐E and ‐F isoforms and humoral immune response in patients , 2005, Cancer science.

[36]  W. Reith,et al.  The bare lymphocyte syndrome and the regulation of MHC expression. , 2001, Annual review of immunology.

[37]  Yi Zheng,et al.  Characterization of a Brain-specific Rho GTPase-activating Protein, p200RhoGAP* , 2003, The Journal of Biological Chemistry.